JP2012515548A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012515548A5 JP2012515548A5 JP2011547913A JP2011547913A JP2012515548A5 JP 2012515548 A5 JP2012515548 A5 JP 2012515548A5 JP 2011547913 A JP2011547913 A JP 2011547913A JP 2011547913 A JP2011547913 A JP 2011547913A JP 2012515548 A5 JP2012515548 A5 JP 2012515548A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- effector
- target
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004027 cell Anatomy 0.000 claims description 105
- 238000000034 method Methods 0.000 claims description 95
- 239000012636 effector Substances 0.000 claims description 34
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 33
- 210000000822 natural killer cell Anatomy 0.000 claims description 23
- 239000000758 substrate Substances 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 11
- 230000009089 cytolysis Effects 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- 102000004127 Cytokines Human genes 0.000 claims description 6
- 108090000695 Cytokines Proteins 0.000 claims description 6
- 238000000151 deposition Methods 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 102000001398 Granzyme Human genes 0.000 claims description 4
- 108060005986 Granzyme Proteins 0.000 claims description 4
- 102100037850 Interferon gamma Human genes 0.000 claims description 4
- 108010074328 Interferon-gamma Proteins 0.000 claims description 4
- 108010002350 Interleukin-2 Proteins 0.000 claims description 4
- 102000000588 Interleukin-2 Human genes 0.000 claims description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 230000003013 cytotoxicity Effects 0.000 claims description 3
- 231100000135 cytotoxicity Toxicity 0.000 claims description 3
- 238000002372 labelling Methods 0.000 claims description 3
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 2
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 2
- 102000003814 Interleukin-10 Human genes 0.000 claims description 2
- 108090000174 Interleukin-10 Proteins 0.000 claims description 2
- 108090000978 Interleukin-4 Proteins 0.000 claims description 2
- 102000004388 Interleukin-4 Human genes 0.000 claims description 2
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims description 2
- KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 claims description 2
- 230000003321 amplification Effects 0.000 claims description 2
- 230000003834 intracellular effect Effects 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 229930192851 perforin Natural products 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims 4
- 238000012935 Averaging Methods 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000002101 lytic effect Effects 0.000 claims 1
- 238000002493 microarray Methods 0.000 claims 1
- 230000008823 permeabilization Effects 0.000 claims 1
- 210000002845 virion Anatomy 0.000 description 9
- 238000001514 detection method Methods 0.000 description 6
- 108010029697 CD40 Ligand Proteins 0.000 description 5
- 102100032937 CD40 ligand Human genes 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000006166 lysate Substances 0.000 description 3
- 208000031886 HIV Infections Diseases 0.000 description 2
- 208000037357 HIV infectious disease Diseases 0.000 description 2
- 230000005875 antibody response Effects 0.000 description 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
- 230000015788 innate immune response Effects 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 description 1
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 1
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 description 1
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 description 1
- 102100025137 Early activation antigen CD69 Human genes 0.000 description 1
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 1
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 description 1
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
- 101001018097 Homo sapiens L-selectin Proteins 0.000 description 1
- 102100033467 L-selectin Human genes 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011225 antiretroviral therapy Methods 0.000 description 1
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- DZNKOAWEHDKBEP-UHFFFAOYSA-N methyl 2-[6-[bis(2-methoxy-2-oxoethyl)amino]-5-[2-[2-[bis(2-methoxy-2-oxoethyl)amino]-5-methylphenoxy]ethoxy]-1-benzofuran-2-yl]-1,3-oxazole-5-carboxylate Chemical group COC(=O)CN(CC(=O)OC)C1=CC=C(C)C=C1OCCOC(C(=C1)N(CC(=O)OC)CC(=O)OC)=CC2=C1OC(C=1OC(=CN=1)C(=O)OC)=C2 DZNKOAWEHDKBEP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14610609P | 2009-01-21 | 2009-01-21 | |
| US61/146,106 | 2009-01-21 | ||
| PCT/US2009/050411 WO2010085275A1 (en) | 2009-01-21 | 2009-07-13 | Compositions and methods for assessing cytotoxicity of single cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015094509A Division JP6017620B2 (ja) | 2009-01-21 | 2015-05-05 | 単一細胞の細胞傷害性を査定するための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012515548A JP2012515548A (ja) | 2012-07-12 |
| JP2012515548A5 true JP2012515548A5 (https=) | 2013-03-21 |
Family
ID=42356144
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011547913A Withdrawn JP2012515548A (ja) | 2009-01-21 | 2009-07-13 | 単一細胞の細胞傷害性を査定するための組成物および方法 |
| JP2015094509A Active JP6017620B2 (ja) | 2009-01-21 | 2015-05-05 | 単一細胞の細胞傷害性を査定するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015094509A Active JP6017620B2 (ja) | 2009-01-21 | 2015-05-05 | 単一細胞の細胞傷害性を査定するための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9244071B2 (https=) |
| EP (1) | EP2389446B1 (https=) |
| JP (2) | JP2012515548A (https=) |
| KR (1) | KR20110134386A (https=) |
| CN (2) | CN102388145A (https=) |
| AU (1) | AU2009338127B2 (https=) |
| CA (1) | CA2689681C (https=) |
| IL (1) | IL213938A0 (https=) |
| RU (1) | RU2532228C2 (https=) |
| SG (2) | SG10201401643PA (https=) |
| WO (1) | WO2010085275A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5675638B2 (ja) | 2008-12-04 | 2015-02-25 | マサチューセッツ インスティテュート オブ テクノロジー | アレルギー反応を診断するための方法 |
| US9404924B2 (en) | 2008-12-04 | 2016-08-02 | Massachusetts Institute Of Technology | Method of performing one-step, single cell RT-PCR |
| SG10201401643PA (en) | 2009-01-21 | 2014-08-28 | Massachusetts Inst Technology | Methods for assessing cytotoxicity of single cells |
| EP2646798B1 (en) | 2010-12-03 | 2017-06-28 | Cellply S.R.L. | Microanalysis of cellular function |
| US10571475B2 (en) * | 2010-12-03 | 2020-02-25 | Cellply S.R.L. | Rapid screening of monoclonal antibodies |
| WO2013090404A2 (en) * | 2011-12-13 | 2013-06-20 | Single Cell Technology, Inc. | Method of screening a plurality of single secreting cells for functional activity |
| US20150191772A1 (en) | 2012-06-29 | 2015-07-09 | Danmarks Tekniske Universitet | Method of charging a test carrier and a test carrier |
| EP4148118A1 (en) * | 2012-08-24 | 2023-03-15 | Yale University | System, device and method for high-throughput multi-plexed detection |
| WO2015031190A1 (en) * | 2013-08-26 | 2015-03-05 | President And Fellows Of Harvard College | Determination of immune cells and other cells |
| RU2019136370A (ru) | 2014-01-31 | 2019-11-25 | Агбайоми, Инк. | Модифицированные средства биоконтроля и их применение |
| US9877486B2 (en) | 2014-01-31 | 2018-01-30 | AgBiome, Inc. | Methods of growing plants using modified biological control agents |
| US10584366B2 (en) | 2014-12-03 | 2020-03-10 | IsoPlexis Corporation | Analysis and screening of cell secretion profiles |
| US10488321B2 (en) | 2015-03-19 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Devices and methods for high-throughput single cell and biomolecule analysis and retrieval in a microfluidic chip |
| WO2016154620A1 (en) | 2015-03-26 | 2016-09-29 | University Of Houston System | Integrated functional and molecular profiling of cells |
| US12071663B2 (en) | 2016-01-15 | 2024-08-27 | Massachusetts Institute Of Technology | Semi-permeable arrays for analyzing biological systems and methods of using same |
| WO2017165791A1 (en) | 2016-03-25 | 2017-09-28 | President And Fellows Of Harvard College | Microfluidic determination of immune and other cells |
| US20190106666A1 (en) * | 2016-03-30 | 2019-04-11 | Sony Corporation | Cell observation device, method for evaluating activity level of immune cells, and method for controlling quality of immune cells |
| CA3027317A1 (en) | 2016-06-14 | 2017-12-21 | Cellply S.R.L. | Screening kit and method |
| CN106086171A (zh) * | 2016-06-15 | 2016-11-09 | 广州中大南沙科技创新产业园有限公司 | 一种抑制肿瘤细胞增殖的药物筛选方法 |
| CN109563539A (zh) | 2016-06-15 | 2019-04-02 | 慕尼黑路德维希马克西米利安斯大学 | 使用dna纳米技术的单分子检测或定量 |
| WO2018049418A1 (en) | 2016-09-12 | 2018-03-15 | IsoPlexis Corporation | System and methods for multiplexed analysis of cellular and other immunotherapeutics |
| EP3532600A4 (en) * | 2016-10-19 | 2020-09-16 | General Automation LAB Technologies Inc. | HIGH RESOLUTION SYSTEMS, KITS, DEVICES AND METHODS FOR SCREENING MICRO-ORGANISMS AND OTHER HIGH-PERFORMANCE MICROBIOLOGICAL APPLICATIONS |
| EP3538891B1 (en) | 2016-11-11 | 2022-01-05 | Isoplexis Corporation | Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells |
| US11085912B2 (en) * | 2016-12-14 | 2021-08-10 | University Of Cincinnati | Methods of diagnosing Clostridium difficile infection or recurrence in a subject |
| SE543211C2 (en) | 2017-06-29 | 2020-10-27 | Mabtech Production Ab | Method and system for analyzing Fluorospot assays |
| JP2021505157A (ja) | 2017-12-07 | 2021-02-18 | マサチューセッツ インスティテュート オブ テクノロジー | 単一細胞分析 |
| CN108728356B (zh) * | 2018-05-23 | 2022-02-22 | 北京科技大学 | 用于不同三维细胞团配对的装置及共培养方法 |
| EP3911953A4 (en) * | 2019-01-16 | 2022-08-31 | Yantai AusBio Laboratories Co., Ltd. | AUTOMATED LIQUID HANDLING SYSTEM AND PROCESS FOR SEPARATION OF BIOLOGICAL SAMPLES FOR MICROSCOPIC ANALYZES |
| US11357787B2 (en) | 2019-02-18 | 2022-06-14 | Nb Health Laboratory Co., Ltd. | Method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent |
| US12064768B2 (en) | 2020-02-21 | 2024-08-20 | Northeastern University | Single cell isolation and processing system with reversible well shape |
| JP2025535563A (ja) | 2022-11-07 | 2025-10-24 | シェンノン バイオテクノロジーズ インコーポレイテッド | 細胞－細胞相互作用のハイスループットスクリーニングのためのマイクロ流体デバイス |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL68507A (en) | 1982-05-10 | 1986-01-31 | Univ Bar Ilan | System and methods for cell selection |
| SU1650094A1 (ru) * | 1987-12-29 | 1991-05-23 | Научно-исследовательский институт проктологии | Способ диагностики прот женности активного воспалени в толстой кишке при неспецифическом звенном колите |
| US6410252B1 (en) | 1995-12-22 | 2002-06-25 | Case Western Reserve University | Methods for measuring T cell cytokines |
| US6210910B1 (en) | 1998-03-02 | 2001-04-03 | Trustees Of Tufts College | Optical fiber biosensor array comprising cell populations confined to microcavities |
| AU4200900A (en) * | 1999-04-09 | 2000-11-14 | Human Genome Sciences, Inc. | 49 human secreted proteins |
| EP1192176A4 (en) * | 1999-06-11 | 2003-03-05 | Human Genome Sciences Inc | 49 HUMAN SECRETED PROTEINS |
| US7332286B2 (en) * | 2001-02-02 | 2008-02-19 | University Of Pennsylvania | Peptide or protein microassay method and apparatus |
| US20020141906A1 (en) | 2001-03-30 | 2002-10-03 | American Type Culture Collection | Microtiter plate sealing cover with well identifiers |
| WO2007035633A2 (en) | 2005-09-16 | 2007-03-29 | President & Fellows Of Harvard College | Screening assays and methods |
| US20110124520A1 (en) | 2008-05-30 | 2011-05-26 | Massachuesetts Institute Of Technology | Compositions and Methods for Spatial Separation and Screening of Cells |
| JP5675638B2 (ja) | 2008-12-04 | 2015-02-25 | マサチューセッツ インスティテュート オブ テクノロジー | アレルギー反応を診断するための方法 |
| US9404924B2 (en) | 2008-12-04 | 2016-08-02 | Massachusetts Institute Of Technology | Method of performing one-step, single cell RT-PCR |
| SG10201401643PA (en) | 2009-01-21 | 2014-08-28 | Massachusetts Inst Technology | Methods for assessing cytotoxicity of single cells |
| US8569046B2 (en) | 2009-02-20 | 2013-10-29 | Massachusetts Institute Of Technology | Microarray with microchannels |
-
2009
- 2009-07-13 SG SG10201401643PA patent/SG10201401643PA/en unknown
- 2009-07-13 AU AU2009338127A patent/AU2009338127B2/en not_active Ceased
- 2009-07-13 SG SG2011049459A patent/SG172889A1/en unknown
- 2009-07-13 CN CN2009801551526A patent/CN102388145A/zh active Pending
- 2009-07-13 KR KR1020117018895A patent/KR20110134386A/ko not_active Ceased
- 2009-07-13 WO PCT/US2009/050411 patent/WO2010085275A1/en not_active Ceased
- 2009-07-13 US US13/145,300 patent/US9244071B2/en active Active
- 2009-07-13 JP JP2011547913A patent/JP2012515548A/ja not_active Withdrawn
- 2009-07-13 CN CN201510140107.0A patent/CN104745669A/zh active Pending
- 2009-07-13 RU RU2011134898/10A patent/RU2532228C2/ru not_active IP Right Cessation
- 2009-07-13 CA CA2689681A patent/CA2689681C/en not_active Expired - Fee Related
- 2009-07-13 EP EP09839012.3A patent/EP2389446B1/en not_active Not-in-force
-
2011
- 2011-07-05 IL IL213938A patent/IL213938A0/en unknown
-
2015
- 2015-05-05 JP JP2015094509A patent/JP6017620B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012515548A5 (https=) | ||
| JP6017620B2 (ja) | 単一細胞の細胞傷害性を査定するための組成物および方法 | |
| JP2015144617A5 (https=) | ||
| Angin et al. | Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection | |
| Quigley et al. | CXCR5+ CCR7–CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles | |
| Clute et al. | Cross-reactive influenza virus–specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus–associated infectious mononucleosis | |
| Mongkolsapaya et al. | Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever | |
| Hammer et al. | HLA type-independent method to monitor polyoma BK virus-specific CD4+ and CD8+ T-cell immunity | |
| Auclair et al. | Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection | |
| Liu et al. | Sequential dysfunction and progressive depletion of Candida albicans-specific CD4 T cell response in HIV-1 infection | |
| EP3511347A1 (en) | Construction of recombined gene of chimeric antigen receptor for treatment of hiv infection, and application thereof | |
| KR20150036186A (ko) | 유세포 측정법을 이용한 ｒｎａ 측정에 의한 ｔ-세포 활성화에 대한 신속한 검정 | |
| Moskovljevic et al. | Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy | |
| Rizzo et al. | Role of KIR receptor in NK regulation during viral infections | |
| Gonzales et al. | Alterations in germinal center formation and B cell activation during severe Orientia tsutsugamushi infection in mice | |
| Jedema et al. | Successful generation of primary virus-specific and anti-tumor T-cell responses from the naive donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells | |
| Michaëlsson et al. | The frequency of CD127low expressing CD4+ CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis | |
| Cohen et al. | Isolation of viable antigen-specific CD4 T cells by CD40L surface trapping | |
| US20230126784A1 (en) | A method to generate chimeric antigen receptor (car) t-cells (car-t cells) from pathogen-specific cytotoxic lymphocytes to enable the subsequent in vivo modulation of their functional activity | |
| Gangaev et al. | Identification and characterization of an immunodominant SARS-CoV-2-specific CD8 T cell response | |
| JP2007535668A5 (https=) | ||
| Uhl et al. | Integration of Avidity and Differentiation is enabled by CD8+ T-cell sensing of IFN-γ | |
| Doyle | Understanding the Impact of Hepatitis C Virus Infection and Cure on the Human Liver Immune System | |
| Sikora | Selecting and Sequencing Clonally Expanded CD8+ T Cells | |
| Parish-Gause et al. | 279-P: Eosinophil granular proteins: Potential participants in anti-cancer cocktail soup (s) |